Advertisement
UK markets closed
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • CRUDE OIL

    82.83
    -0.53 (-0.64%)
     
  • GOLD FUTURES

    2,333.20
    -8.90 (-0.38%)
     
  • DOW

    38,441.30
    -62.39 (-0.16%)
     
  • Bitcoin GBP

    51,495.51
    -2,078.12 (-3.88%)
     
  • CMC Crypto 200

    1,398.09
    -26.01 (-1.83%)
     
  • NASDAQ Composite

    15,674.56
    -22.08 (-0.14%)
     
  • UK FTSE All Share

    4,374.06
    -4.69 (-0.11%)
     

Does Pfizer's Latest News Snatch a Big Market Opportunity Away From Moderna?

Does Pfizer's Latest News Snatch a Big Market Opportunity Away From Moderna?

Pfizer (NYSE: PFE) just scored another first. The U.S. Food and Drug Administration (FDA) granted it authorization for the use of its coronavirus vaccine in a new age group -- 12 through 15. In December, Pfizer became the first company to win Emergency Use Authorization (EUA) for a coronavirus vaccine.